CONTROLLED RELEASE PHARMACEUTICAL DOSAGE FORMS OF A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR

Details for Australian Patent Application No. 2003201713 (hide)

Owner PFIZER PRODUCTS INC.

Inventors SUTTON, Steven, Charles; APPEL, Leah, Elizabeth; CURATOLO, William, John

Pub. Number AU-A-2003201713

PCT Number PCT/IB03/00209

PCT Pub. Number WO2003/063868

Priority 60/353,719 01.02.02 US

Filing date 20 January 2003

Wipo publication date 2 September 2003

International Classifications

A61K 031/4706 - 4-Aminoquinolines

A61K 009/22 Medicinal preparations characterised by special physical form - Sustained or differential release type

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 60/353,719 01.02.02 US

18 September 2003 Application Open to Public Inspection

  Published as AU-A-2003201713

15 June 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003201714-METHOD AND SYSTEM FOR SECURING MOBILE IPV6 HOME ADDRESS OPTION USING INGRESS FILTERING

2003201712-N-SUBSTITUTED SPIROPIPERIDINE COMPOUNDS AS LIGANDS FOR ORL-1 RECEPTOR